PE-22-28 is a synthetic peptide analog of Spadin, researched for its potential antidepressant and cognitive-enhancing effects.
Spadin analog that may modulate TREK-1 potassium channels, potentially offering rapid antidepressant-like effects.
Nootropic peptides researched for cognitive function, memory, focus, neuroprotection, and neurogenesis.
This peptide is primarily sold as a research-only compound in lyophilized powder form. It is not approved for human use and is intended for laboratory research purposes only.
Cognitive enhancement
Cognitive support
Cognitive enhancement
Brain aging research
Browse our verified directory of pharmacies, telehealth providers, and research vendors.
Browse ProvidersThe information provided about PE-22-28 is for educational and research purposes only. This content is not intended as medical advice, diagnosis, or treatment recommendation.PE-22-28 is a research compound and may not be approved for human use. Always consult with a qualified healthcare provider before considering any peptide therapy. The Peptide List does not sell peptides or provide medical services.
This website is for informational purposes only and does not constitute medical advice. Consult a licensed physician before using any peptides. Provider listings do not constitute endorsements. None of the statements on this site have been evaluated by the FDA.